Esense-Lab
- Short interest
- 0.05%
- +0.05 pp 30d
- as of 17 Jan 2018
- Reported shorts
- 15K
- Shares on issue
- 31.778M
Esense-Lab (ESE) Short Interest
Esense-Lab (ASX:ESE) had 0.05% of shares reported as short positions as of 17 Jan 2018, representing 15,000 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Esense-Lab
Esense-Lab was an Israeli-based biotechnology company focused on the research, development, and commercialization of proprietary terpene formulations. The company aimed to create natural, non-cannabinoid products for various industries, including food, cosmetics, and the emerging cannabis sector. It sought to leverage the therapeutic and aromatic properties of terpenes to enhance product efficacy and consumer experience.
Company profile →Esense-Lab (ASX:ESE) has 0.05% of its shares on issue reported as short positions as of 17 Jan 2018, or about 15,000 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.12% in May 2017. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Company details
Company information is being updated. Check back soon.
Be the first to discuss ESE
Start a research thread or post the first pulse update